Chesney Castleberry, M.D.  castleberry_c@kids.wustl.edu

Assistant Professor- Pending
Cardiology

phone: (314) 454-6095

Clinical Interests

Primary clinical interest is in the field of heart failure, cardiomyopathy, mechanical circulatory support, and heart transplantation. Also have clinical interest in aquired immune deficiencies especially as they relate to sequale of cardiac operations and transplantation.

Education

  • BA, Texas A&M University2001
  • MD, University of Texas Medical School2005

Training

  • Resident, Children’s Memorial Hospital2005 - 2008
  • Fellow, Children’s Hospital of Wisconsin2008 - 2011
  • Advanced Fellow, Lucile Packard Children’s Hospital2011 - 2012

Licensure and Board Certification

  • WI, Wisconsin License 2008
  • American Board of Pediatrics 2009
  • CA, California License 2012
  • Advanced Cardiovascular Life Support 2012
  • American Board of Pediatric Cardiology 2013
  • OH, Ohio License 2013
  • Thoratec Heartmate II 2013
  • KY, Kentucky License 2013
  • Syncardia C2 2014
  • Syncardia Freedom Driver 2014
  • Thoratec Heartmate II 2014
  • Pediatric Advanced Life Support 2015
  • MO, Pediatric Advanced Life Support 2015

Honors

  • Medical College of Wisconsin Fellow Research Award2010
  • International Society of Heart and Lung Transplant Registry, Early Career Award2014
  • Mentor- Summer Undergraduate Research Fellowship, Capstone Poster Presentation- 1st Place Award2015

Recent Publications view all (9)


Publication Co-Authors

  1. Allosensitization does not alter post-transplant outcomes in pediatric patients bridged to transplant with a ventricular assist device. Pediatr Transplant. 2016;20(4):559-64. PMID:27102953 
  2. Early initiation of mTOR inhibitors in children with heart transplantation: A propensity-based registry analysis. J Heart Lung Transplant. 2016;35(2):253-5. PMID:26612055 
  3. Basiliximab treatment for autoimmune bowel disease in a pediatric heart transplant patient. Pediatr Transplant. 2015;19(7):E165-9. doi:10.1111/petr.12584  PMID:26374667 
  4. The influence of pulmonary resistance on the success of pediatric heart transplantation: Are there still boundaries? Pediatr Transplant. 2015;19(6):580-1. doi:10.1111/petr.12560  PMID:26215796 
  5. Pediatric heart transplant waiting list mortality in the era of ventricular assist devices. J Heart Lung Transplant. 2015;34(1):82-8. doi:10.1016/j.healun.2014.09.018  PMID:25447574 
  6. Transplantation in the highly sensitized pediatric patient. Circulation. 2014;129(22):2313-9. PMID:24891624 
  7. Hypoalbuminemia and poor growth predict worse outcomes in pediatric heart transplant recipients. Pediatr Transplant. 2014;18(3):280-7. doi:10.1111/petr.12239  PMID:24646199 
  8. Highly sensitive noninvasive cardiac transplant rejection monitoring using targeted quantification of donor-specific cell-free deoxyribonucleic acid. J Am Coll Cardiol. 2014;63(12):1224-6. doi:10.1016/j.jacc.2013.09.029  PMID:24140666 
  9. Stenting of the right ventricular outflow tract in the high-risk infant with cyanotic teratology of Fallot. Pediatr Cardiol. 2014;35(3):423-30. doi:10.1007/s00246-013-0796-z  PMID:24096718 
Wash U School of Medicine
Children's Hospital St. Louis
Children's Discovery Institute
© 2017 by Washington University in St. Louis
One Brookings Drive, St. Louis, MO 63130